Sun Pharma's $11.75B Organon Deal: India's Biggest Pharma Bet

When Sun Pharmaceutical Industries said it would buy America's Organon for an enterprise value of US$11.

Under the definitive agreement, Sun Pharma will acquire all outstanding shares of Organon & Co.

The transaction is expected to close in early 2027, subject to the usual gauntlet: antitrust and regulatory clearances across multiple jurisdictions, plus approval from Organon's o

For scale, this deal eclipses the year's other blockbusters.

Organon is not a household name in India, but its products are.